The Heart Rhythm Society endorsed the document on May 30, 2017.
July 5, 2017—Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1–2% of the general population. An earlier detection of AF could allow an earlier adequate management to avoid later complications. Screening for AF is not yet recommended by all scientific AF guidelines, even in specific at-risk populations. This document summarizes the available data, discusses the different strategies, and highlights the importance of implicating all stakeholders from the various health systems.
The Heart Rhythm Society endorsed the document on April 30, 2017.
July 10, 2017—This consensus document addresses definitions, clinical importance, implications, and management of device-detected subclinical atrial tachyarrhythmias, as well as current developments in the field.
March 5, 2012—The purpose of the 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of atrial fibrillation. It reports on the findings of a Task Force, convened by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS) and charged with defining the indications, techniques, and outcomes of this procedure.
February 14, 2011—This guideline update states that dabigatran, a new antithrombotic agent that was recently approved by the U.S. Food and Drug Administration, is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation. The update is a joint publication of the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), and the Heart Rhythm Society (HRS).
March 28, 2014 - A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society; developed in collaboration with the Society of Thoracic Surgeons. The goal of this guideline is to establish revised guidelines for optimum management of atrial fibrillation. This guideline supersedes the "2006 ACC/AHA/ESC Guideline for the Management of Patients with Atrial Fibrillation" and the two subsequent focused updates from 2011.
April 2003 — This consensus statement provides a simple way to characterize an episode of Atrial Fibrillation. It is the result of a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, now known as Heart Rhythm Society.
May 13, 2015 - The Heart Rhythm Society, in partnership with the National Stroke Association, developed an survey initiative that sought characterize the impact of stroke on AF patients and their caregivers; gaps in knowledge and perspective among physicians and patients; and barriers to effective communication and optimal anticoagulation use.
November 18, 2014 - The Heart Rhythm Society convened a research symposium on December 9–10, 2013, in Washington, DC, that focused on the prevention of atrial fibrillation (AF) as well as AF-related stroke and morbidity.Attendees sought to summarize advances in understanding AF since a 2008 National Institutes of Health(NIH) conference on this topic and to identify continued knowledge gaps and current research priorities. This resultant whitepaper was developed in collaboration with and endorsed by the European Heart Rhythm Association (EHRA) and the Canadian Heart Rhythm Society (CHRS). It summarizes the deliberations of the attendees in an effort to accelerate progress toward preventing AF and its consequences.